VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 151 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $45,981,123 | +37.4% | 8,138,252 | -0.0% | 0.00% | 0.0% |
| Q1 2024 | $33,454,910 | -5.0% | 8,139,881 | -2.5% | 0.00% | 0.0% |
| Q4 2023 | $35,221,670 | +20.6% | 8,346,367 | +23.5% | 0.00% | 0.0% |
| Q3 2023 | $29,199,385 | -59.0% | 6,759,117 | -37.5% | 0.00% | -50.0% |
| Q2 2023 | $71,238,005 | +3.9% | 10,810,016 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $68,571,734 | -10.1% | 10,098,930 | -2.2% | 0.00% | 0.0% |
| Q4 2022 | $76,313,678 | -21.2% | 10,326,614 | +5.4% | 0.00% | -33.3% |
| Q3 2022 | $96,790,000 | -8.3% | 9,796,633 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $105,540,000 | -4.3% | 9,682,578 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $110,246,000 | -28.5% | 9,747,619 | -0.8% | 0.00% | -25.0% |
| Q4 2021 | $154,158,000 | -7.3% | 9,825,375 | +1.3% | 0.00% | -20.0% |
| Q3 2021 | $166,294,000 | -21.6% | 9,702,122 | -1.7% | 0.01% | -16.7% |
| Q2 2021 | $212,230,000 | +40.8% | 9,866,539 | -1.7% | 0.01% | +50.0% |
| Q1 2021 | $150,699,000 | +16.9% | 10,033,270 | +2.2% | 0.00% | 0.0% |
| Q4 2020 | $128,965,000 | +43.9% | 9,814,597 | +5.8% | 0.00% | +33.3% |
| Q3 2020 | $89,626,000 | -16.9% | 9,278,160 | -1.6% | 0.00% | -25.0% |
| Q2 2020 | $107,870,000 | +15.0% | 9,429,230 | +4.1% | 0.00% | -20.0% |
| Q1 2020 | $93,809,000 | -39.1% | 9,054,848 | -3.5% | 0.01% | -16.7% |
| Q4 2019 | $154,022,000 | +27.7% | 9,385,881 | +3.4% | 0.01% | +20.0% |
| Q3 2019 | $120,579,000 | -4.8% | 9,079,647 | +1.0% | 0.01% | 0.0% |
| Q2 2019 | $126,636,000 | -19.4% | 8,987,677 | +5.2% | 0.01% | -28.6% |
| Q1 2019 | $157,137,000 | -31.5% | 8,540,148 | -2.7% | 0.01% | -41.7% |
| Q4 2018 | $229,272,000 | +12.9% | 8,774,342 | -0.8% | 0.01% | +33.3% |
| Q3 2018 | $202,999,000 | +114.8% | 8,845,222 | +78.3% | 0.01% | +125.0% |
| Q2 2018 | $94,506,000 | +31.4% | 4,960,924 | +16.3% | 0.00% | +33.3% |
| Q1 2018 | $71,900,000 | +3.5% | 4,267,002 | -6.6% | 0.00% | 0.0% |
| Q4 2017 | $69,436,000 | -13.1% | 4,568,159 | +2.4% | 0.00% | -25.0% |
| Q3 2017 | $79,867,000 | +9.7% | 4,461,931 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $72,824,000 | +35.0% | 4,467,718 | +15.9% | 0.00% | +33.3% |
| Q1 2017 | $53,944,000 | +35862.7% | 3,853,200 | +40908.9% | 0.00% | – |
| Q4 2016 | $150,000 | -54.8% | 9,396 | -52.9% | 0.00% | – |
| Q3 2016 | $332,000 | +33.3% | 19,934 | -10.1% | 0.00% | – |
| Q2 2016 | $249,000 | +492.9% | 22,183 | +344.5% | 0.00% | – |
| Q1 2016 | $42,000 | +250.0% | 4,990 | +280.0% | 0.00% | – |
| Q4 2015 | $12,000 | -47.8% | 1,313 | -35.5% | 0.00% | – |
| Q3 2015 | $23,000 | +155.6% | 2,037 | +176.4% | 0.00% | – |
| Q2 2015 | $9,000 | 0.0% | 737 | -21.0% | 0.00% | – |
| Q1 2015 | $9,000 | -30.8% | 933 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | +62.5% | 933 | +20.1% | 0.00% | – |
| Q3 2014 | $8,000 | -38.5% | 777 | 0.0% | 0.00% | – |
| Q2 2014 | $13,000 | -13.3% | 777 | -14.3% | 0.00% | – |
| Q1 2014 | $15,000 | +36.4% | 907 | 0.0% | 0.00% | – |
| Q4 2013 | $11,000 | +10.0% | 907 | 0.0% | 0.00% | – |
| Q3 2013 | $10,000 | +42.9% | 907 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,010,000 | $32,060,000 | 6.59% |
| Palo Alto Investors LP | 4,203,270 | $67,042,000 | 3.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,424,676 | $54,624,000 | 2.25% |
| ARMISTICE CAPITAL, LLC | 580,000 | $9,251,000 | 2.19% |
| Avoro Capital Advisors LLC | 381,466 | $6,084,000 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 135,817 | $2,166,000 | 0.98% |
| ACUTA CAPITAL PARTNERS, LLC | 162,600 | $2,593,000 | 0.96% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 450,847 | $7,191,000 | 0.50% |
| Cheyne Capital Management (UK) LLP | 52,000 | $831,000 | 0.47% |
| OXFORD ASSET MANAGEMENT LLP | 757,507 | $12,082,000 | 0.43% |